Pancreatitis News and Research

RSS
Pancreatitis is inflammation of the pancreas. The pancreas is a large gland behind the stomach and close to the duodenum—the first part of the small intestine. The pancreas secretes digestive juices, or enzymes, into the duodenum through a tube called the pancreatic duct. Pancreatic enzymes join with bile—a liquid produced in the liver and stored in the gallbladder—to digest food. The pancreas also releases the hormones insulin and glucagon into the bloodstream. These hormones help the body regulate the glucose it takes from food for energy.

Normally, digestive enzymes secreted by the pancreas do not become active until they reach the small intestine. But when the pancreas is inflamed, the enzymes inside it attack and damage the tissues that produce them.

Pancreatitis can be acute or chronic. Either form is serious and can lead to complications. In severe cases, bleeding, infection, and permanent tissue damage may occur.
Completion of Phase I study of CPSI-2364 announced by Cytokine PharmaSciences

Completion of Phase I study of CPSI-2364 announced by Cytokine PharmaSciences

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

Lipid assessment in vascular disease can be simplified by measuring cholesterol levels

Lipid assessment in vascular disease can be simplified by measuring cholesterol levels

Second-quarter fiscal 2010 results announced by Repligen

Second-quarter fiscal 2010 results announced by Repligen

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

FDA approves an expanded indication for BYETTA injection

FDA approves an expanded indication for BYETTA injection

AMT inks agreement with Progenika Biopharma for development of LPLchip

AMT inks agreement with Progenika Biopharma for development of LPLchip

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Repligen completes patient treatment in its Phase 3 RG1068 clinical trial

Repligen completes patient treatment in its Phase 3 RG1068 clinical trial

Alnara Pharmaceuticals’ announces results of its international Phase 3 study of liprotamase

Alnara Pharmaceuticals’ announces results of its international Phase 3 study of liprotamase

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Early detection of PGAP may reduce mortality rate

Early detection of PGAP may reduce mortality rate

Patient outcomes better in highly rated hospitals than others

Patient outcomes better in highly rated hospitals than others

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

FDA approves Daiichi Sankyo's sNDA for Welchol

FDA approves Daiichi Sankyo's sNDA for Welchol

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON